VYNE Therapeutics Inc. 8-K

What Happened
VYNE Therapeutics, Inc. (VYNE) filed a Form 8-K on May 21, 2026 (Item 7.01) to disclose that Yarrow Bioscience, Inc. published an investor presentation dated May 21, 2026. VYNE has made that presentation available on the investor section of its website and attached the presentation as Exhibit 99.1 to the filing.

Key Details

• Event: Regulation FD Disclosure (Item 7.01) — investor presentation published and shared.
• Date of presentation and filing: May 21, 2026.
• Exhibit included: Presentation attached as Exhibit 99.1; interactive XBRL cover page included as Exhibit 104.
• Presentation posted online at VYNE’s investor presentations page: https://vynetherapeutics.com/investors-media/events_presentations/

Why It Matters
This 8-K is a routine Regulation FD disclosure that informs investors the company is sharing updated investor materials originating from Yarrow Bioscience. The filing itself does not report financial results or corporate actions, but provides investors direct access to the presentation content for further review.